NUS researchers uncovers promising cancer target for liposarcoma
(National University of Singapore) A study conducted by a team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore has revealed a close association between liposarcoma (LPS), a type of cancer that develops from fat cells, and the bromodomain and extraterminal (BET) protein family. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 3, 2019 Category: International Medicine & Public Health Source Type: news
Family dynamics: Molecules from the same family have different effects in cancer prognosis
(Hiroshima University) Researchers at Hiroshima University have found that different levels of two molecules of the same family -- TIMP-1 and TIMP-4 -- can influence prognosis of liposarcoma. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 13, 2019 Category: International Medicine & Public Health Source Type: news
Oregon teen, 15, recovering in the hospital after remove a nearly 25-POUND tumor from his stomach
Kristion Kim, 15, from Tualatin, Oregon, was diagnosed with liposarcoma, a rare fat tissue tumor in February 2019. A few days later, doctors removed a nearly 25-pound mass. (Source: the Mail online | Health)
Source: the Mail online | Health - March 18, 2019 Category: Consumer Health News Source Type: news
This man was teased for his ‘beer belly.’ It turned out to be a 77-pound cancerous tumor.
Hector Hernandez had a 77-pound cancerous tumor called a retroperitoneal liposarcoma growing in his abdomen. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - November 27, 2018 Category: Consumer Health News Authors: Lindsey Bever Source Type: news
Big, Fat Tumors: Liposarcomas Can Top 70 Pounds
Sarcomas in the soft tissues (such as fat, nerves, ligaments, muscles) of all types are rare, accounting for less than 1% of all malignant tumors in adults. In 2018, the American Cancer Society estimates, about 13,000 new soft-tissue sarcomas of all types will be diagnosed, and about 5,000 Americans will die of them. (Source: WebMD Health)
Source: WebMD Health - October 5, 2018 Category: Consumer Health News Source Type: news
Liposarcoma
Title: LiposarcomaCategory: Diseases and ConditionsCreated: 4/25/2018 12:00:00 AMLast Editorial Review: 4/25/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 25, 2018 Category: Cancer & Oncology Source Type: news
Medical News Today: Liposarcoma: Symptoms, diagnosis, and treatment
A liposarcoma may grow anywhere in the body. What is a liposarcoma and what are the symptoms? Learn about the causes and how it may be treated. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 4, 2017 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news
Liposarcoma Symptoms and Treatment
Title: Liposarcoma Symptoms and TreatmentCategory: Doctor's& Expert's views on SymptomsCreated: 9/24/2014 12:00:00 AMLast Editorial Review: 4/7/2017 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 7, 2017 Category: Cancer & Oncology Source Type: news
Aldoxorubicin Improves PFS in Some Relapsed/Refractory Sarcomas
Aldoxorubicin yielded significantly better progression-free survival over investigator ’s choice of various chemotherapy options in patients with relapsed or refractory leiomyosarcoma and liposarcoma, according to updated results of a phase III trial. (Source: CancerNetwork)
Source: CancerNetwork - December 30, 2016 Category: Cancer & Oncology Authors: Dave Levitan Tags: News Sarcoma Source Type: news
New Cancer Drug Approvals From 2016
Chemotherapy is one of the most powerful tools we have to treat cancer, and research continues to find new chemotherapy drugs as well as new uses for existing ones. At the same time, newer types of drugs are continually being developed that work in different ways to attack cancer cells.They include targeted therapy, which aims to more precisely identify cancer cells while doing less damage to normal cells, and immunotherapy, which uses the body’s own immune system to help find and destroy cancer.Before any new drug can be sold in the United States, it has to go through an approval process by the Food and Drug Adminis...
Source: American Cancer Society :: News and Features - December 26, 2016 Category: Cancer & Oncology Tags: Advanced Cancer Source Type: news
Eribulin in liposarcoma: Added benefit not proven
(Institute for Quality and Efficiency in Health Care) Neither the results from a study of direct comparison nor from an indirect comparison were suitable for the assessment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 7, 2016 Category: Global & Universal Source Type: news
Eisai Bewildered as German Institute for Quality and Efficiency in Health Care (IQWIG) Fails to Recognise Additional Benefit of Halaven(R) (eribulin) in the Treatment of Advanced Liposarcoma
Assessment ignores unprecedented overall survival benefit for eribulin in advanced liposarcoma[1]
HATFIELD, England, September 4, 2016 -- (Healthcare Sales & Marketing Network) -- The German Institute for Quality and Efficiency in Health Care (IQWiG) h... Biopharmaceuticals, Oncology, Regulatory Eisai, Halaven, eribulin, Liposarcoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 5, 2016 Category: Pharmaceuticals Source Type: news
Former Toronto Mayor Rob Ford's Rare Abdominal Cancer, Explained
Rob Ford, the controversial former Toronto mayor who was known both for smoking crack cocaine in office and his intense popularity among conservative working-class voters, died today at the age of 46. The cause of death was not announced, but Ford was being treated for rare abdominal cancer called pleomorphic liposarcoma -- a diagnosis he received in 2014. "It's rare to have a highly successful outcome with a pleomorphic liposarcoma once it's spread," Dr. Brian Van Tine, a medical oncologist at Washington University in St. Louis, told the Canadian Press. Liposarcomas belong to a class of tumors that begin ...
Source: Science - The Huffington Post - March 22, 2016 Category: Science Source Type: news
Former Toronto Mayor Rob Ford's Rare Abdominal Cancer, Explained
Rob Ford, the controversial former Toronto mayor who was known both for smoking crack cocaine in office and his intense popularity among conservative working-class voters, died today at the age of 46. The cause of death was not announced, but Ford was being treated for rare abdominal cancer called pleomorphic liposarcoma -- a diagnosis he received in 2014. "It's rare to have a highly successful outcome with a pleomorphic liposarcoma once it's spread," Dr. Brian Van Tine, a medical oncologist at Washington University in St. Louis, told the Canadian Press. Liposarcomas belong to a class of tumors that begin ...
Source: Healthy Living - The Huffington Post - March 22, 2016 Category: Consumer Health News Source Type: news
Rob Ford died suffering from pleomorphic liposarcoma
Former Toronto Mayor Rob Ford died Tuesday while suffering from a rare type of cancer known as pleomorphic liposarcoma. (Source: CBC | Health)
Source: CBC | Health - March 22, 2016 Category: Consumer Health News Tags: News/Canada/Toronto Source Type: news
